Study Links Higher Inflammation Marker GlycA to Increased Heart Health Risks
A recent study published in the European Journal of Preventive Cardiology has highlighted a concerning link between systemic inflammation and cardiovascular health. Researchers found that higher levels of glycoprotein acetyls (GlycA), a marker of inflammation, are associated with an increased risk of major adverse cardiovascular events (MACE), including heart attacks and strokes. The study analyzed data from 488,079 participants in the UK Biobank, revealing that individuals with elevated GlycA levels had a smaller left ventricular volume in the heart, increased wall thickness, and reduced diastolic function. Cheng-Han Chen, MD, an interventional cardiologist, noted that those with the highest GlycA levels had a 43% higher risk of experiencing significant cardiovascular events compared to those with the lowest levels. However, Chen emphasized that while these findings are significant, they do not establish a direct causal relationship between elevated GlycA and cardiovascular events, indicating a need for further research. The study also examined how environmental factors, such as smoking and obesity, contribute to inflammation levels. It was found that depression, visceral fat, and fat distribution in the abdomen were linked to higher GlycA levels, suggesting that lifestyle factors play a crucial role in inflammation and heart health. Michelle Routhenstein, a preventive cardiology dietitian, added that GlycA should be viewed as one component of a broader cardiovascular risk assessment, alongside other factors like cholesterol levels and blood pressure. The researchers also noted that higher levels of physical activity and healthier dietary choices were associated with lower GlycA levels, reinforcing the importance of lifestyle modifications in managing cardiovascular health. Additionally, the study indicated that socioeconomic status could influence inflammation levels, with higher status correlating with lower GlycA levels. This research underscores the complex interplay between genetics, lifestyle, and inflammation in determining cardiovascular risk, suggesting that both inherited traits and modifiable lifestyle factors must be considered in future risk assessments.




